Articles of association set the company’s internal rules. They govern how directors are appointed and removed, how board meetings are called, what constitutes a quorum, how votes are taken and how conflicts of interest are managed. The Companies Act 2006 provides model articles for many companies, but growing businesses often adopt bespoke provisions to reflect their funding arrangements and ownership structure. Harper James is a UK full-service commercial law firm advising start-ups, scale-ups and established companies on the laws of England and Wales.
The articles define the board’s authority, but they do not operate in isolation. A shareholders’ agreement often adds reserved matters requiring shareholder consent, such as issuing shares, taking on significant borrowing, selling substantial assets or changing the business. The board must also comply with directors’ statutory duties, including the duty to act within the company’s constitution. For a broader reference on corporate and commercial developments, consult this curated legal resource.
Before approving a significant transaction, directors should check the articles, any shareholders’ agreement and the company’s statutory records. The chair should confirm that notice was properly given and that the meeting is quorate. The minutes should record the decision, the commercial reasoning, declared interests and any conditions attached to approval. If a director has an interest in a proposed contract, the articles and Companies Act requirements should be checked before that director participates in the discussion or vote.
Governance arrangements often need review after an investment round, acquisition, founder departure or change in board composition. Investors may seek enhanced consent rights, while founders may need clear procedures for deadlock, director removal and share transfers. A practical review compares the articles with the shareholders’ agreement, financing documents and the company’s actual decision-making process. Inconsistencies should be resolved before the next major board approval, not during a transaction when timing and negotiating leverage are already constrained.